APA

Grunnet M., Christensen I. J., Lassen U., Jensen L. H., Lydolph M., Lund I. K., Thurison T., Høyer-Hansen G. & Mau-Sørensen M. (20141230). Prognostic significance of circulating intact and cleaved forms of urokinase plasminogen activator receptor in inoperable chemotherapy treated cholangiocarcinoma patients. : Clinical biochemistry.

Chicago

Grunnet M, Christensen I J, Lassen U, Jensen L H, Lydolph M, Lund I K, Thurison T, Høyer-Hansen G and Mau-Sørensen M. 20141230. Prognostic significance of circulating intact and cleaved forms of urokinase plasminogen activator receptor in inoperable chemotherapy treated cholangiocarcinoma patients. : Clinical biochemistry.

Harvard

Grunnet M., Christensen I. J., Lassen U., Jensen L. H., Lydolph M., Lund I. K., Thurison T., Høyer-Hansen G. and Mau-Sørensen M. (20141230). Prognostic significance of circulating intact and cleaved forms of urokinase plasminogen activator receptor in inoperable chemotherapy treated cholangiocarcinoma patients. : Clinical biochemistry.

MLA

Grunnet M, Christensen I J, Lassen U, Jensen L H, Lydolph M, Lund I K, Thurison T, Høyer-Hansen G and Mau-Sørensen M. Prognostic significance of circulating intact and cleaved forms of urokinase plasminogen activator receptor in inoperable chemotherapy treated cholangiocarcinoma patients. : Clinical biochemistry. 20141230.